Caplin Point Laboratories Limited – NSE:CAPLIPOINT.NS

One share of Caplin Point Laboratories Limited stock can currently be purchased for approximately $872.45.

Unfortunately, Caplin Point Laboratories Limited's (CAPLIPOINT.NS) next earnings date is currently unknown.

Yes, Caplin Point Laboratories Limited pays dividends and its trailing 12-month yield is 0.19% with 0% payout ratio. The last Caplin Point Laboratories Limited stock dividend of $0 was paid on 12 Sep 2025.

Caplin Point Laboratories Limited has a market capitalization of 183.76B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 32.76% to 16.77B US dollars.

Caplin Point Laboratories Limited is traded on the NSE under the ticker symbol "CAPLIPOINT.NS".

Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.

Shares of Caplin Point Laboratories Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

Caplin Point Laboratories Limited's management team includes the following people:

• Dr. Sridhar Ganesan MD & Whole Time Director(age: 70, pay: $5,640,000)

As Jul 2024, Caplin Point Laboratories Limited employs 1,642 workers.

Caplin Point Laboratories Limited is publicly traded company for more then 11 years since IPO on 23 Jun 2014.

The official website for Caplin Point Laboratories Limited is caplinpoint.net.

Caplin Point Laboratories Limited can be reached via phone at +91 44 2496 8000.